ABC | Volume 112, Nº2, February 2019

Original Article Vizentin et al Prevalence of dyslipidemia in adolescents Arq Bras Cardiol. 2019; 112(2):147-151 Table 3 – Prevalence of dyslipidemias according to nutritional status by BMI Lipids Nutritional diagnosis p value Total (n: 239) Eutrophy (n: 52) Overweight (n: 60) Obesity (n: 127) TC (mg/dl) Normal 155(64.8%) 35 (22.6%) 39 (25.2%) 81 (52.3%) 0.90 Changed 84(35.2%) 17 (20.2%) 21 (25%) 46 (54.8%) LDL-c (mg/dl) Normal 213 (89.1%) 43 (23%) 50 (23.5%) 114 (53.5%) 0.18 Changed 26 (10.9%) 3 (11.5%) 10 (38.5%) 13 (50.0%) HDL-c (mg/dl) Normal 118 (49.4%) 35 (29.7%) 31 (26.3%) 52 (44.0%) 0.01* Changed 121 (50.6%) 17 (14.0%) 29 (24.0%) 75 (62.0%) TG (mg/dl) Normal 195 (81.6%) 47 (24.1%) 51 (26.2%) 97 (49.7%) Changed 44 (18.4%) 5 (11.4%) 9 (20.4%) 30 (68.2%) 0.06 Statistical test:Chisquare;*Statisticallysignificantdifference(p<0.05);TC: totalcholesterol;LDL-c: lowdensity lipoprotein;HDL-c:highdensity lipoprotein;TG: triglycerides. Table 4 – Bivariate and multivariate linear regression analysis between lipid profile and anthropometric variables ** Variables BMI WC p value Gross Coef (95% CI) p value Adjusted Coef (95% CI) p value Gross Coef (95% CI) p value Adjusted Coef (95% CI) TC (mg/dl) 0.02 (-0.01 – 0.04) 0.19 0.01 (-0.01 - 0.04) 0.33 0.05 (-0.02 – 0.13) 0.17 0.06 (-0.02 – 0.13) 0.13 LDL-c (mg/dl) 0.03 (-0.00 – 0.06) 0.07 0.02 (-0.01 - 0.06) 0.14 0.07 (-0.01 – 0.16) 0.08 0.08 (-0.01 – 0.16) 0.08 HDL-c (mg/dl) -0.12 (-0.18 – -0.05) p < 0.01 * -0.13 (-0.20 – -0.07) p < 0.01 * -0.22 (-0.47 – 0.02) 0.07 -0.23 (-0.47 – 0.02) 0.07 TG (mg/dl) 0.03 (0.02 – 0.06) p < 0.01 * 0.04 (0.02 – 0.05) p < 0.01 * 0.05 (0.00 – 0.10) 0.03* 0.06 (0.01 – 0.10) 0.02* Statistical test: Bivariate and multivariate linear regression; *Statistically significant difference (p < 0.05); **Adjusted for gender and skin color; BMI: body mass index; WC: waist circumference; COEF: coefficient; CI: confidence interval; TC: total cholesterol; LDL-c: low density lipoprotein; HDL-c: high density lipoprotein; TG: triglyceride. show an alert to the multiprofessional team about the need for a greater incentive to healthy lifestyle measures in the above-mentioned population. Author contributions Conception and design of the research, acquisition of data, analysis and interpretation of the data, writing of the manuscript and critical revision of the manuscript for intellectual content: Vizentin NP, Cardoso PMS, Maia CAG, Alves IP, Aranha GL, Giannini DT; statistical analysis: Vizentin NP, Giannini DT. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding There were no external funding sources for this study. Study Association This study is not associatedwith any thesis or dissertationwork. Ethics approval and consent to participate This study was approved by the Ethics Committee o f t h eCE P-HUP E u nd e r t h e p r o t o c o l numb e r 0193.0.228.000‑11. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study. 150